Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.65
+0.03 (0.22%)
At close: Aug 11, 2026, 4:00 PM EDT
13.65
0.00 (0.00%)
Pre-market: Aug 12, 2026, 7:38 AM EDT

Organon & Co. Revenue

Organon & Co. had revenue of $1.56B in the quarter ending June 30, 2026, a decrease of -2.26%. This brings the company's revenue in the last twelve months to $6.13B, down -2.45% year-over-year. In the year 2025, Organon & Co. had annual revenue of $6.22B, down -2.92%.

Revenue (ttm)
$6.13B
Revenue Growth
-2.45%
P/S Ratio
0.59
Revenue / Employee
$612,700
Employees
10,000
Market Cap
3.58B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.22B-187.00M-2.92%
Dec 31, 20246.40B140.00M2.24%
Dec 31, 20236.26B89.00M1.44%
Dec 31, 20226.17B-130.00M-2.06%
Dec 31, 20216.30B-228.00M-3.49%
Dec 31, 20206.53B-1.25B-16.01%
Dec 31, 20197.78B-2.00B-20.46%
Dec 31, 20189.78B-723.00M-6.89%
Dec 31, 201710.50B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Pfizer63.70B
AstraZeneca61.37B
Sanofi55.89B
Novo Nordisk50.34B
Bristol-Myers Squibb Company49.19B
GSK plc44.05B
Amgen38.10B
Gilead Sciences30.46B
Revenue Rankings